Blood Biomarkers to Predict the Prognosis of a Stroke Patient Undergoing Mechanical Thrombectomy
TROMBOPOCT
1 other identifier
observational
400
1 country
2
Brief Summary
The goal of this observational study is to evaluate the accuracy of a panel of blood biomarkers and clinical variables in predicting the prognosis of stroke patients treated by mechanical thrombectomy, specifically to predict futile recanalization and mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 9, 2024
CompletedFirst Submitted
Initial submission to the registry
June 14, 2024
CompletedFirst Posted
Study publicly available on registry
June 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedJune 21, 2024
May 1, 2024
12 months
June 14, 2024
June 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Specificity and sensibility of blood biomarkers in combination with neurological scales (NIHSS) determined before the thrombectomy intervention to predict the prognosis of the patient (functional dependence and mortality).
through the study completion, an average of one year
Secondary Outcomes (1)
Percentage of patients who suffer a futile recanalization after a mechanical thrombectomy.
3 months
Interventions
Duplex Point of Care test to measure the concentration of blood biomarkers (FABP+NT-proBNP) associated to Large Vessel Occlusion in blood samples used in combination with an APP.
Eligibility Criteria
Stroke patients with large vessel occlusion treated by mechanical thrombectomy
You may qualify if:
- Patients \> 18 years old.
- Patient in whom a mechanical thrombectomy is performed.
You may not qualify if:
- Impossibility of getting a blood sample.
- Impossibility of performing the test (Invalid results)
- Refusal to provide the informed consent by the patient/relative.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hospital Universitario Reina Sofía
Córdoba, Spain
Hospital Universitario Virgen Rocío
Seville, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2024
First Posted
June 21, 2024
Study Start
April 9, 2024
Primary Completion
April 1, 2025
Study Completion
July 1, 2025
Last Updated
June 21, 2024
Record last verified: 2024-05